Israt Jahan Bulbul
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Israt Jahan Bulbul has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Mohammad Abdur Rashid
Department of Pharmaceutical Chemistry University of Dhaka Dhaka Bangladesh
2 shared publications - Mohammad Rashedul Haque
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Dhaka, Dhaka 1000, Bangladesh
2 shared publications - Nusratun Nahar
Department of Pharmacy, Southeast University, Dhaka, Bangladesh
2 shared publications - Sabiha Ferdowsy Koly
Department of Pharmacy, Southeast University, Dhaka, Bangladesh
2 shared publications - Sherejad Sanam
Department of Pharmacy, Southeast University, Dhaka, Bangladesh
2 shared publications - Adwiza Chakraborty Bishakha
School of Pharmacy , BRAC University , Dhaka , Bangladesh , bracu.ac.bd
1 shared publication
Latest Publications
- Open Access
- 30 September 2026
- Published by Oriental Scientific Publishing Company in Biomedical and Pharmacology Journal
- Vol. 3 (19) , 2420-2428
Pharmacopeial Quality Assessment of Five Commercially Available Enteric-Coated Esomeprazole Magnesium Tablets in Bangladesh
Esomeprazole, the optically active S-isomer of omeprazole, is extensively used as a proton pump inhibitor for the treatment of gastroesophageal reflux disease and other gastric acid-related conditions. The present investigation was undertaken to assess the pharmaceutical quality of enteric-coated esomeprazole magnesium tablets available from five different Bangladeshi manufacturers. Evaluation was performed by analyzing key physicochemical characteristics including tablet hardness, friability, disintegration behavior, dissolution performance, and drug content assay. All analyses were conducted according to recognized pharmacopeial procedures to determine the uniformity and quality consistency among the selected brands. During disintegration testing in 0.1N hydrochloric acid for two hours, no tablets showed signs of disintegration, indicating satisfactory integrity of the enteric coating and resistance to gastric conditions. When transferred to phosphate buffer solution (pH 6.8), complete tablet disintegration occurred within 30 minutes for all tested samples. The hardness of tablets ranged between 5.443 and 6.509 kg/cm², demonstrating acceptable mechanical durability. Dissolution testing revealed limited drug release in acidic medium, ranging from 2.54% to 4.45%, which complies with the pharmacopeial requirement where stated the value is of less than 10%. In contrast, dissolution in phosphate buffer (pH 6.8) showed rapid and complete drug release within 60 minutes, with release values ranging from 100.9% to 102.4%. Assay analysis confirmed that the active pharmaceutical ingredient content of all brands remained within the accepted pharmacopeial range of 96.32% to 99.20%. These results suggest that the evaluated brands meet established pharmacopeial quality requirements and are likely to ensure reliable therapeutic effectiveness in the treatment of acid-related disorders.
- 30 September 2026
- Published by Oriental Scientific Publishing Company in Biomedical and Pharmacology Journal
- Vol. 3 (19) , 2420-2428
Open AccessPharmacopeial Quality Assessment of Five Commercially Available Enteric-Coated Esomeprazole Magnesium Tablets in Bangladesh
Esomeprazole, the optically active S-isomer of omeprazole, is extensively used as a proton pump inhibitor for the treatment of gastroesophageal reflux disease and other gastric acid-related conditions. The present investigation was undertaken to assess the pharmaceutical quality of enteric-coated esomeprazole magnesium tablets available from five different Bangladeshi manufacturers. Evaluation was performed by analyzing key physicochemical characteristics including tablet hardness, friability, disintegration behavior, dissolution performance, and drug content assay. All analyses were conducted according to recognized pharmacopeial procedures to determine the uniformity and quality consistency among the selected brands. During disintegration testing in 0.1N hydrochloric acid for two hours, no tablets showed signs of disintegration, indicating satisfactory integrity of the enteric coating and resistance to gastric conditions. When transferred to phosphate buffer solution (pH 6.8), complete tablet disintegration occurred within 30 minutes for all tested samples. The hardness of tablets ranged between 5.443 and 6.509 kg/cm², demonstrating acceptable mechanical durability. Dissolution testing revealed limited drug release in acidic medium, ranging from 2.54% to 4.45%, which complies with the pharmacopeial requirement where stated the value is of less than 10%. In contrast, dissolution in phosphate buffer (pH 6.8) showed rapid and complete drug release within 60 minutes, with release values ranging from 100.9% to 102.4%. Assay analysis confirmed that the active pharmaceutical ingredient content of all brands remained within the accepted pharmacopeial range of 96.32% to 99.20%. These results suggest that the evaluated brands meet established pharmacopeial quality requirements and are likely to ensure reliable therapeutic effectiveness in the treatment of acid-related disorders.
- Open Access
- 1 January 2026
- Published by Wiley in BioMed Research International
- Vol. 2026 (1) , 8861594
Antioxidant, Anti‐inflammatory, Analgesic, and Antiarthritic Potentialities of Methanolic Extract of Fruit Husk of Nypa fruticans Wurmb, Established by In Silico Analysis
This study investigates the bioactive components and biological activities of the methanolic husk extract of Nypa fruticans Wurmb (MNF) through gas chromatography–mass spectrometry (GC‐MS) analysis. The MNF extract was identified to contain several bioactive components, including alkaloids, glycosides, phenols, tannins, and resins, as established through preliminary phytochemical screening tests. After finding the presence of antioxidant components in the qualitative antioxidative assay, we went to conduct quantitative tests where the total contents of phenolics, flavonoids, and tannins were estimated as 179.43 ± 3.99 mg GAE/g, 179.43 ± 3.99 mg QE/g, and 29.25 ± 0.29 mg TAE/g, respectively. The extract demonstrated notable antioxidant activity in DPPH free radical scavenging (IC 50 36.28 μ g/mL) and ferric reducing antioxidant power (83.27 % ± 0.02 % reduction) assays. The extract demonstrated notable in vitro anti‐inflammatory and antiarthritic properties in a dose‐dependent manner, as indicated by human red blood cell (HRBC) membrane stabilization (74.63 % ± 0.84 % at 5000 μ g/mL) and protein denaturation (88.77 % ± 0.31 % inhibition at 500 μ g/mL), relative to standards. The anti‐inflammatory efficacy of MNF extract was confirmed via an in vivo carrageenan‐induced inflammatory study, showing an 85.49% reduction in edema at the maximum dosage of 600 mg/kg. The extract demonstrated significant ( p < 0.05, p < 0.01, and p < 0.0001) and dose‐dependent analgesic effects in acetic acid–induced writhing and formalin‐induced pain assays. Molecular docking studies conducted with the selected compounds against potential targets identified 1‐(3,6,6‐trimethyl‐1,6,7,7a‐tetrahydrocyclopenta[c]pyran‐1‐yl) ethanone as the best candidate with promising analgesic and anti‐inflammatory potential, demonstrated by its high binding affinity comparable to or exceeding that of the selected standard drugs. Our findings indicate that N. fruticans fruit husk may serve as a viable source of natural chemicals possessing antioxidant, analgesic, anti‐inflammatory, and antiarthritic properties, demonstrating potential therapeutic effects in alleviating diseases associated with inflammatory responses.
- 1 January 2026
- Published by Wiley in BioMed Research International
- Vol. 2026 (1) , 8861594
Open AccessAntioxidant, Anti‐inflammatory, Analgesic, and Antiarthritic Potentialities of Methanolic Extract of Fruit Husk of Nypa fruticans Wurmb, Established by In Silico Analysis
This study investigates the bioactive components and biological activities of the methanolic husk extract of Nypa fruticans Wurmb (MNF) through gas chromatography–mass spectrometry (GC‐MS) analysis. The MNF extract was identified to contain several bioactive components, including alkaloids, glycosides, phenols, tannins, and resins, as established through preliminary phytochemical screening tests. After finding the presence of antioxidant components in the qualitative antioxidative assay, we went to conduct quantitative tests where the total contents of phenolics, flavonoids, and tannins were estimated as 179.43 ± 3.99 mg GAE/g, 179.43 ± 3.99 mg QE/g, and 29.25 ± 0.29 mg TAE/g, respectively. The extract demonstrated notable antioxidant activity in DPPH free radical scavenging (IC 50 36.28 μ g/mL) and ferric reducing antioxidant power (83.27 % ± 0.02 % reduction) assays. The extract demonstrated notable in vitro anti‐inflammatory and antiarthritic properties in a dose‐dependent manner, as indicated by human red blood cell (HRBC) membrane stabilization (74.63 % ± 0.84 % at 5000 μ g/mL) and protein denaturation (88.77 % ± 0.31 % inhibition at 500 μ g/mL), relative to standards. The anti‐inflammatory efficacy of MNF extract was confirmed via an in vivo carrageenan‐induced inflammatory study, showing an 85.49% reduction in edema at the maximum dosage of 600 mg/kg. The extract demonstrated significant ( p < 0.05, p < 0.01, and p < 0.0001) and dose‐dependent analgesic effects in acetic acid–induced writhing and formalin‐induced pain assays. Molecular docking studies conducted with the selected compounds against potential targets identified 1‐(3,6,6‐trimethyl‐1,6,7,7a‐tetrahydrocyclopenta[c]pyran‐1‐yl) ethanone as the best candidate with promising analgesic and anti‐inflammatory potential, demonstrated by its high binding affinity comparable to or exceeding that of the selected standard drugs. Our findings indicate that N. fruticans fruit husk may serve as a viable source of natural chemicals possessing antioxidant, analgesic, anti‐inflammatory, and antiarthritic properties, demonstrating potential therapeutic effects in alleviating diseases associated with inflammatory responses.
- Open Access
- 8 November 2025
- Published by Horizon E-Publishing Group in Plant Science Today
Advancing herbal therapeutics through nanotechnology: Innovations in drug delivery and pharmacokinetic enhancement
Herbal medicine has long been integral to global healthcare systems due to its therapeutic versatility and cultural significance. Nevertheless, its clinical utility is hampered by inherent limitations, such as low solubility and instability of numerous herbal bioactive. Nanotechnology has emerged as a modern approach to overcoming these challenges by improving botanical compounds’ solubility, stability and targeted delivery. The objective of this review article is to conduct a critical assessment of the application of nanotechnology to enhance the pharmacological properties of plant-derived therapeutics in herbal medicine. This review also includes an analysis of the bioavailability and site-specific delivery of herbal bioactive by examining advancements in Nano formulations, such as liposomes, polymeric nanoparticles, Nano emulsions and lipid-based carriers. Furthermore, the review discusses the obstacles to clinical adoption of nanotechnology, including regulatory issues, production scaling issues and the necessity for longer-term safety investigations. This discussion will be supportive to guarantee nanotechnology's safe and efficient incorporation into herbal medicine. Nanotechnology has noteworthy importance for herbal medicines, like, to improve solubility, pharmacological activity enhancement, bioavailability, stability enhancement and site-specific delivery of herbal bioactives. Nanotechnology's transformative potential for herbal medicine necessitates large-scale human trials and comparative nano-delivery system investigations and interdisciplinary collaboration.
- 8 November 2025
- Published by Horizon E-Publishing Group in Plant Science Today
Open AccessAdvancing herbal therapeutics through nanotechnology: Innovations in drug delivery and pharmacokinetic enhancement
Herbal medicine has long been integral to global healthcare systems due to its therapeutic versatility and cultural significance. Nevertheless, its clinical utility is hampered by inherent limitations, such as low solubility and instability of numerous herbal bioactive. Nanotechnology has emerged as a modern approach to overcoming these challenges by improving botanical compounds’ solubility, stability and targeted delivery. The objective of this review article is to conduct a critical assessment of the application of nanotechnology to enhance the pharmacological properties of plant-derived therapeutics in herbal medicine. This review also includes an analysis of the bioavailability and site-specific delivery of herbal bioactive by examining advancements in Nano formulations, such as liposomes, polymeric nanoparticles, Nano emulsions and lipid-based carriers. Furthermore, the review discusses the obstacles to clinical adoption of nanotechnology, including regulatory issues, production scaling issues and the necessity for longer-term safety investigations. This discussion will be supportive to guarantee nanotechnology's safe and efficient incorporation into herbal medicine. Nanotechnology has noteworthy importance for herbal medicines, like, to improve solubility, pharmacological activity enhancement, bioavailability, stability enhancement and site-specific delivery of herbal bioactives. Nanotechnology's transformative potential for herbal medicine necessitates large-scale human trials and comparative nano-delivery system investigations and interdisciplinary collaboration.
- Open Access
- 31 March 2025
- Published by Oriental Scientific Publishing Company in Biomedical and Pharmacology Journal
- Vol. 18 (1) , 581-591
Assessment of Antimicrobial, Cytotoxic and Antioxidant Potentials of n-Hexane, Chloroform and Ethyl Acetate Extracts of Sonneratia apetala Banks Fruits
This study evaluated the antioxidant, antimicrobial and cytotoxic activities of different fractions from the ethanolic crude extract of Sonneratia apetala fruits (Family: Lythraceae). Antimicrobial activity was assessed using the disc diffusion method with ciprofloxacin and fluconazole as reference standards. Among the fractions, the chloroform fraction demonstrated mild to moderate antimicrobial activity (8-20 mm zone of inhibition), with the highest activity against Pseudomonas aeruginosa (20 mm) and a minimum inhibitory concentration (MIC) of 32 µg. The lethality test for brine shrimp was used to assess cytotoxicity, showing LC50 values of 22.41 µg/ml (n-hexane), 20.53 µg/ml (chloroform), and 24.60 µg/ml (ethyl acetate), compared to vincristine sulfate (8.66 µg/ml). Antioxidant activity, determined via DPPH radical scavenging, revealed IC50 values of 42.03 µg/ml (n-hexane), 13.76 µg/ml (chloroform), and 49.99 µg/ml (ethyl acetate), with ascorbic acid as the standard (IC50 45.47 µg/ml). The highest amount of total phenolic content was detected in the chloroform fraction (26.88 mg GAE/g of extract). These findings suggest the chloroform fraction of S. apetala possesses significant antioxidant and cytotoxic potential, alongside moderate antimicrobial activity.
- 31 March 2025
- Published by Oriental Scientific Publishing Company in Biomedical and Pharmacology Journal
- Vol. 18 (1) , 581-591
Open AccessAssessment of Antimicrobial, Cytotoxic and Antioxidant Potentials of n-Hexane, Chloroform and Ethyl Acetate Extracts of Sonneratia apetala Banks Fruits
This study evaluated the antioxidant, antimicrobial and cytotoxic activities of different fractions from the ethanolic crude extract of Sonneratia apetala fruits (Family: Lythraceae). Antimicrobial activity was assessed using the disc diffusion method with ciprofloxacin and fluconazole as reference standards. Among the fractions, the chloroform fraction demonstrated mild to moderate antimicrobial activity (8-20 mm zone of inhibition), with the highest activity against Pseudomonas aeruginosa (20 mm) and a minimum inhibitory concentration (MIC) of 32 µg. The lethality test for brine shrimp was used to assess cytotoxicity, showing LC50 values of 22.41 µg/ml (n-hexane), 20.53 µg/ml (chloroform), and 24.60 µg/ml (ethyl acetate), compared to vincristine sulfate (8.66 µg/ml). Antioxidant activity, determined via DPPH radical scavenging, revealed IC50 values of 42.03 µg/ml (n-hexane), 13.76 µg/ml (chloroform), and 49.99 µg/ml (ethyl acetate), with ascorbic acid as the standard (IC50 45.47 µg/ml). The highest amount of total phenolic content was detected in the chloroform fraction (26.88 mg GAE/g of extract). These findings suggest the chloroform fraction of S. apetala possesses significant antioxidant and cytotoxic potential, alongside moderate antimicrobial activity.
- Open Access
- 30 September 2021
- Published by Oriental Scientific Publishing Company in Biomedical and Pharmacology Journal
- Vol. 14 (3) , 1259-1266
Antidiarrheal Activity of Four Different Species of Litsea Available in Bangladesh
The objective of the present study includes the evaluation of the antidiarrheal properties of the methanol extracts of Litsea deccanensis Gamble (MELD) bark, Litsealancifolia (Roxb.) Hook. f. MELL),Litseaglutinosa Gamble (MELG) and Litsea monopetala Roxb. (MELM) leavesin Swiss albino mice. The antidiarrheal activity was evaluated by measuring percentage inhibition of diarrheal feces, total fecal output, gastrointestinal motility and by using peristaltic indices. Castor oil was used to induce diarrhea in the experimental animal. The experiments were carried out by using three different doses (100, 200, and 400 mg/kg body weight) of these four plant extracts. The number of wet feces and total weight of the feces were significantly (p < 0.05) and dose-dependently reduced by all the plant extracts and this effect was comparable with standard drug. MELD, MELL, MELG and MELM extracts at dose of 400 mg/kg body weight demonstrated diarrheal inhibition by 43.55%, 45.16%, 32.26% and 41.94%, respectively while it was 98.39% for the standard loperamide. Percentage (%) of fecal output for MELD, MELL, MELG and MELM extracts at the dose of 400 mg/kg were 40.14%, 62.27%, 64.06%, 46.26%, respectively.The gastrointestinal motility induced by castor oil was also reduced noticeably (p < 0.05) by all the plant extracts with the increasing doses. The percentage inhibition of gastrointestinal motility at the dose of 400 mg/kg were 26.26%, 33.22%, 32.36% and 22.52% for the MELD, MELL, MELG and MELM extracts respectively, while it was 27.56% for loperamide. In most cases, all the plant extracts can reduce the peristaltic indices which were comparable to control. The obtained results from this study revealed that the methanol extracts of four different species of Litsea found in Bangladesh may have antidiarrheal potential. It also provides the basis for the traditional use of these plants to treat diarrhea.
- 30 September 2021
- Published by Oriental Scientific Publishing Company in Biomedical and Pharmacology Journal
- Vol. 14 (3) , 1259-1266
Open AccessAntidiarrheal Activity of Four Different Species of Litsea Available in Bangladesh
The objective of the present study includes the evaluation of the antidiarrheal properties of the methanol extracts of Litsea deccanensis Gamble (MELD) bark, Litsealancifolia (Roxb.) Hook. f. MELL),Litseaglutinosa Gamble (MELG) and Litsea monopetala Roxb. (MELM) leavesin Swiss albino mice. The antidiarrheal activity was evaluated by measuring percentage inhibition of diarrheal feces, total fecal output, gastrointestinal motility and by using peristaltic indices. Castor oil was used to induce diarrhea in the experimental animal. The experiments were carried out by using three different doses (100, 200, and 400 mg/kg body weight) of these four plant extracts. The number of wet feces and total weight of the feces were significantly (p < 0.05) and dose-dependently reduced by all the plant extracts and this effect was comparable with standard drug. MELD, MELL, MELG and MELM extracts at dose of 400 mg/kg body weight demonstrated diarrheal inhibition by 43.55%, 45.16%, 32.26% and 41.94%, respectively while it was 98.39% for the standard loperamide. Percentage (%) of fecal output for MELD, MELL, MELG and MELM extracts at the dose of 400 mg/kg were 40.14%, 62.27%, 64.06%, 46.26%, respectively.The gastrointestinal motility induced by castor oil was also reduced noticeably (p < 0.05) by all the plant extracts with the increasing doses. The percentage inhibition of gastrointestinal motility at the dose of 400 mg/kg were 26.26%, 33.22%, 32.36% and 22.52% for the MELD, MELL, MELG and MELM extracts respectively, while it was 27.56% for loperamide. In most cases, all the plant extracts can reduce the peristaltic indices which were comparable to control. The obtained results from this study revealed that the methanol extracts of four different species of Litsea found in Bangladesh may have antidiarrheal potential. It also provides the basis for the traditional use of these plants to treat diarrhea.
- 12 December 2020
- Published by Bentham Science Publishers Ltd. in Current Pharmaceutical Design
- Vol. 26 (41) , 5224-5240
COVID-19 Outbreak and Emerging Management through Pharmaceutical Therapeutic Strategy
The latest SARS COV2 coronavirus contributes to a pandemic of millions of COVID-19. As there is no defensive immunity in humans and a virus can overcome inborn immune reaction, it can propagate unhindered, mostly in tissues contaminated. No unique therapies for COVID-19 contaminated patients are available at this time. The insights learned from previous respiratory viral infection control have given guidance into COVID- 19 therapy. Several complementary treatments have been tentatively introduced in hospital environments such as immune-modulators, antiviral, convalescent plasma transfusions and natural products. In COVID-19 patients, some of these therapies have provided substantial curative benefits. Moreover, numerous studies and clinical trials are being carried out in order to determine the efficacy of current pharmaceutical and natural products to establish possible therapeutic strategies for producing novel COVID-19 medicines. We summarized and defined the modes of mechanism, protection and efficacy on the existing therapeutic strategies for diseases linked to COVID-19 infection.
- 12 December 2020
- Published by Bentham Science Publishers Ltd. in Current Pharmaceutical Design
- Vol. 26 (41) , 5224-5240
COVID-19 Outbreak and Emerging Management through Pharmaceutical Therapeutic Strategy
The latest SARS COV2 coronavirus contributes to a pandemic of millions of COVID-19. As there is no defensive immunity in humans and a virus can overcome inborn immune reaction, it can propagate unhindered, mostly in tissues contaminated. No unique therapies for COVID-19 contaminated patients are available at this time. The insights learned from previous respiratory viral infection control have given guidance into COVID- 19 therapy. Several complementary treatments have been tentatively introduced in hospital environments such as immune-modulators, antiviral, convalescent plasma transfusions and natural products. In COVID-19 patients, some of these therapies have provided substantial curative benefits. Moreover, numerous studies and clinical trials are being carried out in order to determine the efficacy of current pharmaceutical and natural products to establish possible therapeutic strategies for producing novel COVID-19 medicines. We summarized and defined the modes of mechanism, protection and efficacy on the existing therapeutic strategies for diseases linked to COVID-19 infection.
- Open Access
- 31 March 2020
- Published by Bangladesh Academy of Sciences in Bangladesh Journal of Botany
- Vol. 49 (1) , 179-183
Pharmacological investigations of Litsea lancifolia (Roxb.) Hook. F.
The petroleum ether, chloroform and ethyl acetate soluble fractions of methanolic extract of Litsea lancifolia Roxb. leaves were subjected to different pharmacological screenings to explore its potential as anti-oxidant, antimicrobial, peripheral analgesic, hypoglycemic and CNS depressing agent. The ethyl acetate soluble fraction showed highest total phenolic content and free radical scavenging activity compared to the standard, acetyl salicylic acid. Potential antimicrobial activity was shown against P. aeruginosa (23.50 mm), E. coli (22.33 mm), B. cereus (18 mm) and S. paratyphi (18 mm). The crude extract demonstrated significant peripheral analgesic (p < 0.01) activity with 69.45 and 77.96% inhibition of acetic acid-induced writhing at 100 and 200 mg/kg b.w., respectively. The crude methanolic extract also showed significant hypoglycemic activity (p < 0.01) at a dose of 500 mg/kg/day on the 7th day of treatment. All the organic soluble fractions exhibited noteworthy (p < 0.001) CNS depressant activity. Taken together, the plant can be considered as a good material for further chemical investigation to isolate the bioactive constituents.
- 31 March 2020
- Published by Bangladesh Academy of Sciences in Bangladesh Journal of Botany
- Vol. 49 (1) , 179-183
Open AccessPharmacological investigations of Litsea lancifolia (Roxb.) Hook. F.
The petroleum ether, chloroform and ethyl acetate soluble fractions of methanolic extract of Litsea lancifolia Roxb. leaves were subjected to different pharmacological screenings to explore its potential as anti-oxidant, antimicrobial, peripheral analgesic, hypoglycemic and CNS depressing agent. The ethyl acetate soluble fraction showed highest total phenolic content and free radical scavenging activity compared to the standard, acetyl salicylic acid. Potential antimicrobial activity was shown against P. aeruginosa (23.50 mm), E. coli (22.33 mm), B. cereus (18 mm) and S. paratyphi (18 mm). The crude extract demonstrated significant peripheral analgesic (p < 0.01) activity with 69.45 and 77.96% inhibition of acetic acid-induced writhing at 100 and 200 mg/kg b.w., respectively. The crude methanolic extract also showed significant hypoglycemic activity (p < 0.01) at a dose of 500 mg/kg/day on the 7th day of treatment. All the organic soluble fractions exhibited noteworthy (p < 0.001) CNS depressant activity. Taken together, the plant can be considered as a good material for further chemical investigation to isolate the bioactive constituents.